Informatie:
Fout:
ID
32706
Beschrijving
Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis
Trefwoorden
Versies (1)
- 13-11-18 13-11-18 -
Houder van rechten
GSK group of companies
Geüploaded op
13 november 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Estimation of Dose Proportionality of Darapladib - 107038
Logs and Repeats: General Adverse Event and Concomitant Medication Questions
Similar models
Logs and Repeats: General Adverse Event and Concomitant Medication Questions
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Date below is the start of the study for this subject
Item
Date below is the start of the study for this subject
date
Item Group
Adverse Event/Concomitant Medications/Repeat Assessment (Check Questions)
Were any concomitant medications taken by the subject during the study?
Item
Were any concomitant medications taken by the subject during the study?
boolean
Did the subject experience any adverse events during the study?
Item
Did the subject experience any adverse events during the study?
boolean
Were any repeat ECGs performed?
Item
Were any repeat ECGs performed?
boolean
Were any repeat/unscheduled PK samples taken?
Item
Were any repeat/unscheduled PK samples taken?
boolean
Were any repeat/unscheduled PD samples taken?
Item
Were any repeat/unscheduled PD samples taken?
boolean